Cost-effectiveness of human papillomavirus vaccination for prevention of cervical cancer in Taiwan
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1472-6963
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cost-effectiveness of human papillomavirus vaccination for prevention of cervical cancer in Taiwan ; volume:10 ; number:1 ; day:11 ; month:1 ; year:2010 ; pages:1-11 ; date:12.2010
BMC health services research ; 10, Heft 1 (11.1.2010), 1-11, 12.2010
- Urheber
-
Liu, Pang-Hsiang
- Beteiligte Personen und Organisationen
-
Hu, Fu-Chang
Lee, Ping-Ing
Chow, Song-Nan
Huang, Chao-Wan
Wang, Jung-Der
SpringerLink (Online service)
- DOI
-
10.1186/1472-6963-10-11
- URN
-
urn:nbn:de:1111-2016072131107
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Liu, Pang-Hsiang
- Hu, Fu-Chang
- Lee, Ping-Ing
- Chow, Song-Nan
- Huang, Chao-Wan
- Wang, Jung-Der
- SpringerLink (Online service)
Ähnliche Objekte (12)
Effect of vaccination age on cost-effectiveness of human papillomavirus vaccination against cervical cancer in China
Cost-effectiveness of human papillomavirus vaccination in Germany
Cervical cancer treatment costs and cost-effectiveness analysis of human papillomavirus vaccination in Vietnam: a PRIME modeling study
Human papillomavirus genotypes in cervical cancer and vaccination challenges in Zimbabwe
Cost-effectiveness of adding vaccination with the AS04-adjuvanted human papillomavirus 16/18 vaccine to cervical cancer screening in Hungary
Cost-effectiveness analysis of different types of human papillomavirus vaccination combined with a cervical cancer screening program in mainland China
Cost-effectiveness of human papillomavirus (HPV) vaccination in Burkina Faso: a modelling study
Concomitant human papillomavirus (HPV) vaccination and screening for elimination of HPV and cervical cancer
Cost-effectiveness analysis of human papillomavirus vaccination in South Africa accounting for human immunodeficiency virus prevalence
Scaling up cervical cancer screening in the midst of human papillomavirus vaccination advocacy in Thailand
A cost-utility analysis of cervical cancer screening and human papillomavirus vaccination in the Philippines
Human papillomavirus testing with Pap triage for cervical cancer prevention in Canada: a cost-effectiveness analysis
Effect of vaccination age on cost-effectiveness of human papillomavirus vaccination against cervical cancer in China
Cost-effectiveness of human papillomavirus vaccination in Germany
Cervical cancer treatment costs and cost-effectiveness analysis of human papillomavirus vaccination in Vietnam: a PRIME modeling study
Human papillomavirus genotypes in cervical cancer and vaccination challenges in Zimbabwe
Cost-effectiveness of adding vaccination with the AS04-adjuvanted human papillomavirus 16/18 vaccine to cervical cancer screening in Hungary
Cost-effectiveness analysis of different types of human papillomavirus vaccination combined with a cervical cancer screening program in mainland China
Cost-effectiveness of human papillomavirus (HPV) vaccination in Burkina Faso: a modelling study
Concomitant human papillomavirus (HPV) vaccination and screening for elimination of HPV and cervical cancer
Cost-effectiveness analysis of human papillomavirus vaccination in South Africa accounting for human immunodeficiency virus prevalence
Scaling up cervical cancer screening in the midst of human papillomavirus vaccination advocacy in Thailand
A cost-utility analysis of cervical cancer screening and human papillomavirus vaccination in the Philippines
Human papillomavirus testing with Pap triage for cervical cancer prevention in Canada: a cost-effectiveness analysis
Effect of vaccination age on cost-effectiveness of human papillomavirus vaccination against cervical cancer in China
Cost-effectiveness of human papillomavirus vaccination in Germany
Cervical cancer treatment costs and cost-effectiveness analysis of human papillomavirus vaccination in Vietnam: a PRIME modeling study
Human papillomavirus genotypes in cervical cancer and vaccination challenges in Zimbabwe
Cost-effectiveness of adding vaccination with the AS04-adjuvanted human papillomavirus 16/18 vaccine to cervical cancer screening in Hungary
Cost-effectiveness analysis of different types of human papillomavirus vaccination combined with a cervical cancer screening program in mainland China
Cost-effectiveness of human papillomavirus (HPV) vaccination in Burkina Faso: a modelling study
Concomitant human papillomavirus (HPV) vaccination and screening for elimination of HPV and cervical cancer
Cost-effectiveness analysis of human papillomavirus vaccination in South Africa accounting for human immunodeficiency virus prevalence
Scaling up cervical cancer screening in the midst of human papillomavirus vaccination advocacy in Thailand
A cost-utility analysis of cervical cancer screening and human papillomavirus vaccination in the Philippines